F 0755
Level of Harm - Minimal harm
or potential for actual harm
Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a
licensed pharmacist.
Based on observations, interviews, and record reviews, the facility failed to provide medications to meet the
needs of 1 of 5 residents sampled for medication administration observation. (Resident #16)
Residents Affected - Few
The findings include:
On 2/19/25 at approximately 10:25 AM, an observation was made of Nurse B, a Licensed Practical Nurse,
administering medications to Resident #16. During this observation, it was observed that the scheduled
medication Azelastine HCL Nasal Solution 137 micrograms (a medication used to relieve sinus congestion)
and Breo Elipta Inhalation aerosol powder 100-25 micrograms/ACT (a medication used to treat Chronic
Obstructive Pulmonary Disease) were not available to administer as ordered to Resident #16.
On 2/19/25 at approximately 10:40 AM, an interview was conducted with Nurse B, who indicated that she
was not sure why the resident was out of these two medications, but that she would contact the pharmacy
to have them sent in, and notify the physician to obtain an order to hold the medication until available.
On 2/19/25 at approximately 10:50 AM, an interview was conducted with the Regional Nurse, who indicated
it was her expectation that all medications be re-ordered from pharmacy in a timely manner.
A review was conducted of the facility policy titled 5.0 Reordering, Changing, & Discontinued Medication
Orders, states,
Policy: The facility will communicate any medication reorders, changes, or discontinuations to the pharmacy
in accordance with pharmacy guidelines and state/federal regulations; thus ensuring standardized process
of communication.
Procedure:
A. All orders must clearly be communicated to the pharmacy by the facility. This includes resident's full
name (first and last).
B. Reorder/Refill Orders1. Refills can be requested by placing the refill strip portion of the medication on the Refill Order Form and
faxing to the pharmacy.
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 5
Event ID:
105628
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105628
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
02/20/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Arabella Health & Wellness of Pensacola
1717 W Avery St
Pensacola, FL 32501
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
Level of Harm - Minimal harm
or potential for actual harm
4. Electronic Orders: Refill orders can be submitted electronically from a prescriber through their escribing
software or through a facilities EMAR (electronic medication record) system as long as the order is not
discontinued.
Residents Affected - Few
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105628
If continuation sheet
Page 2 of 5
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105628
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
02/20/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Arabella Health & Wellness of Pensacola
1717 W Avery St
Pensacola, FL 32501
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0880
Provide and implement an infection prevention and control program.
Level of Harm - Minimal harm
or potential for actual harm
Resident #21
Residents Affected - Few
On 2/19/25 at approximately 9:36 AM, an observation was made of Nurse A during medication
administration for Resident #21. Nurse A was observed to touch the inside of the medication cup, and the
inside of the water cup with her bare hand. Further observations of Nurse A revealed that the nurse failed to
clean the hub of the Lantus insulin pen (a medication used to treat Diabetes type II) with an alcohol swab
prior to applying the needle.
On 2/19/25 at approximately 10:00 AM, an interview was conducted with Nurse A, who indicated that
touching the inside of the medication cup and water cup would be considered an infection control issue.
Nurse A further confirmed that she did not clean the hub of the Lantus insulin pen prior to applying the
needle and this too would be considered an infection control issue.
On 2/19/25 at approximately 10:50 AM, an interview was conducted with the Regional Nurse, who indicated
that it is the facility's expectation that the nurses do not touch the inside of the medication or water cups,
and that the nurses also clean the hub of all insulin pens with alcohol prior to applying the needle.
The Lantus SoloStar pen guide states under How to use your Lantus Solostar pen in 6 steps, Step 2.
Attach the needle. * Wipe the pen tip (rubber seal) with an alcohol swab.
The facility policy titled Infection Prevention and Control Program states,
Policy: This facility has established and maintains an infection prevention and control program designed to
provide a safe, sanitary, and comfortable environment and to help prevent the development and
transmission of communicable diseases and infections as per accepted national standards and guidelines.
Policy Explanation and Compliance Guidelines:
4. Standard Precautions:
d. Licensed staff shall adhere to safe injection and medication administration practices, as described in
relevant facility policies.
Based on observations, interviews, policy review, and record review, the facility failed to wear proper
protective equipment during catheter care for 1 of 1 resident observed during catheter care (Resident #13),
failed to maintain sterile processes during tracheostomy care for 1 of 1 residents observed during
tracheostomy care (Resident #36), failed to implement their legionella (a water born virus) plan for
surveillance and prevention, and failed to follow infection control processes during medication pass for 1 of
5 residents observed during medication pass (Resident #21),
The findings included:
Resident #13
On 2/19/25 at approximately 9:30 AM, an observation of Staff B, a Certified Nursing Assistant
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105628
If continuation sheet
Page 3 of 5
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105628
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
02/20/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Arabella Health & Wellness of Pensacola
1717 W Avery St
Pensacola, FL 32501
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0880
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
(CNA), was conducted as she provided catheter care for Resident #13. Staff B failed to apply a barrier
gown before she provided catheter care for Resident #13, who had been placed on enhanced barrier
precautions to protect him from a catheter associated infections.
A review of the physician orders for Resident #13 was conducted. A foley catheter was ordered to be
inserted for Resident #13 on 1/9/25. Catheter care was ordered to be completed for the resident every shift.
A physician order dated 1/14/25 indicated that the resident was to be placed on enhanced barrier
precautions.
On 2/19/25 at approximately 10:00 AM, an interview was conducted with Staff B. When asked about why
she did not apply a gown during catheter care, the CNA indicated that she should have worn a gown while
she provided catheter care.
On 2/20/25 at approximately 9:00 AM, an interview was conducted with the Director of Nursing (DON). She
was notified that Staff B did not wear a gown during catheter care for Resident #13. The DON indicated that
a gown should have been worn. She indicated that staff retraining has already been initiated.
A review of the facility policy titled Enhanced Barrier Precautions, dated 3/20/2024, was conducted. The
policy states, Enhanced Barrier Precautions is an infection control intervention designed to reduce the
transmission of multidrug-resistant organisms. Enhanced Barrier precautions were indicated to employ
targeted gown and glove use during high contact resident care activities. The policy further indicated that
Enhanced barrier precautions were to be unutilized for residents with urinary catheters to prevent infections
with multi-drug-resistant organisms.
Resident #36
On 2/19/25, an observation was made as Nurse C, a Licensed Practical Nurse (LPN), provided
tracheostomy care to Resident #36. When she opened the sterile kit, the kit was upside down causing the
sterile gloves to come out first and the suction catheter and other items to land on top of the sterile gloves.
Nurse C handled the suction catheter, the container to hold the normal saline, and drain sponge prior to
applying the sterile gloves, thus rendering those items unsterile. During the process, Nurse C touched
multiple surfaces that were not clean as she provided tracheostomy care. Nurse C proceeded to change the
inner canula next using the same gloves she applied at the beginning of the process.
Immediately after the observation, an interview was conducted with Nurse C. She was asked if
tracheostomy care/changing the inner cannula should be conducted as a sterile procedure. She indicated
that she will look at the physician orders to double check and see if sterile procedure should have been
utilized. She later indicated that changing the inner canula should have been completed utilizing sterile
processes. She was asked if she has received training regarding the process for tracheostomy care. She
could not recall when she had been trained.
On 2/20/25 at approximately 9:00 AM, an interview was conducted with the DON. The DON was notified
that there was concerns regarding maintaining sterility during tracheostomy care as Nurse C changed the
resident's inner cannula. The DON indicated that training had been completed regarding tracheostomy care
by the facility recently.
A review of the facility policy for Tracheostomy Care dated 1/5/25 was conducted. The policy
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105628
If continuation sheet
Page 4 of 5
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105628
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
02/20/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Arabella Health & Wellness of Pensacola
1717 W Avery St
Pensacola, FL 32501
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0880
indicated that suctioning should be performed utilizing sterile technique.
Level of Harm - Minimal harm
or potential for actual harm
Legionella plan
Residents Affected - Few
On 2/20/25 at approximately 9:00 AM, the facility's maintenance director was asked to provide information
regarding the facility's water surveillance process. The Maintenance Director indicated that water is being
tested using test strips. A copy of the facility's water testing logs for the past year along with other
documentation regarding the facility's program for prevention of waterborne disease was requested. The
Maintenance Director indicated that water was being tested utilizing test strips but not being logged. He
was asked to provide any documentation regarding the facility water management program along with a
copy of the facility policy and procedure for water management.
The Maintenance Director provided a copy of the facility water management program policy. The policy
indicated that a risk assessment was to be conducted by the water management team annually to identify
where Legionella and other opportunistic waterborne pathogens could grow and spread in the facility's
water system. The policy indicated that the Maintenance Director would maintain the facility's water
management action plan and keep a copy in the facility water management program binder. The policy
indicated that control measures were to be applied to address potential hazards at each control point in the
water system. The policy further stated that a variety of measures would be utilized including physical
controls, temperature management, disinfectant level control, visual inspections, and environmental testing
for pathogens. These measures should be specified in the water management program action plan. Testing
protocols and control limits will be established for each control measure. Individuals responsible for testing
or visual inspections will document findings. The water management team were directed by the policy to
regularly verify that the water management program is being implemented as designed.
The Maintenance Director did not provide information regarding the annual risk assessment as indicated in
the facility's policy. There was no water management provided for review. The facility did not provide
documentation that testing was being performed at the time of the survey.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105628
If continuation sheet
Page 5 of 5